WallStSmart
BIOX

Bioceres Crop Solutions Corp

NASDAQ: BIOX · BASIC MATERIALS · AGRICULTURAL INPUTS

$0.25
+4.80% today

Updated 2026-10-28

Market cap
$16.28M
P/E ratio
—
P/S ratio
0.07x
EPS (TTM)
$-0.70
Dividend yield
—
52W range
$0 – $2
Volume
0.4M

Bioceres Crop Solutions Corp (BIOX) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20152017201820192020202120222023202420252026
Total assets$20.38M$239.87M$196.64M$242.47M$297.56M$394.59M$518.22M$818.06M$852.55M$763.65M$471.30M
Cash & equivalents$2.25M$1.68M$2.22M$3.45M$27.16M$36.05M$33.48M$48.13M$44.47M$32.70M$11.20M
Current assets—$87.77M$85.34M$98.21M$164.69M$211.49M$297.71M$397.11M$408.67M$308.31M$215.20M
Total liabilities$11.61M$160.13M$163.51M$180.37M$237.51M$304.30M$359.92M$487.56M$501.17M$468.43M$407.20M
Current liabilities$7.94M$69.39M$118.68M$116.46M$130.61M$168.04M$222.67M$298.71M$329.31M$337.99M$267.00M
Long-term debt$2.80M$40.95M$25.71M$84.26M$96.65M$86.74M$135.90M$135.88M$122.91M$38.20M—
Shareholder equity$8.77M$38.34M$33.13M$47.30M$45.48M$67.74M$127.61M$298.85M$315.30M$262.81M$39.10M
Retained earnings—$-15.11M$-26.15M$-21.97M$-18.61M$-25.48M$-32.68M$-13.90M$-9.63M$-65.04M—
Accounts receivable—$41.68M$58.69M$59.24M$77.84M$99.15M$128.08M$185.32M$216.03M$177.75M$111.70M
Inventory$971000.00$31.34M$19.37M$27.59M$30.77M$63.35M$126.10M$140.57M$126.22M$89.99M$46.70M
Goodwill$536000.00$25.08M$14.44M$29.80M$25.53M$28.75M$36.07M$112.16M$112.16M$112.16M$36.10M

Frequently asked questions

What is Bioceres Crop Solutions Corp's revenue?

Bioceres Crop Solutions Corp's trailing twelve-month revenue is $237.80M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is BIOX?

In its most recent fiscal year, BIOX ran a gross margin of 34.65%, an operating margin of 0.04%, and a net margin of -96.85%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does BIOX generate?

BIOX produced $35.30M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BIOX's balance sheet healthy?

BIOX holds $11.20M in cash and equivalents against — in long-term debt, on $39.10M of shareholder equity. That debt is best read against the cash flow the business throws off each year.